These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 32854000

  • 1. Abstinence-reinforcing contingency management improves HIV viral load suppression among HIV-infected people who use drugs: A randomized controlled trial.
    Cunningham CO, Arnsten JH, Zhang C, Heo M, Bachhuber MA, Jost JJ, Grossberg R, Stein MR, Sohler NL.
    Drug Alcohol Depend; 2020 Nov 01; 216():108230. PubMed ID: 32854000
    [Abstract] [Full Text] [Related]

  • 2. Daily and near-daily cannabis use is associated with HIV viral load suppression in people living with HIV who use cocaine.
    Slawek DE, Arnsten J, Sohler N, Zhang C, Grossberg R, Stein M, Cunningham CO.
    AIDS Care; 2021 Oct 01; 33(10):1350-1357. PubMed ID: 32748649
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine.
    Carrico AW, Neilands TB, Dilworth SE, Evans JL, Gόmez W, Jain JP, Gandhi M, Shoptaw S, Horvath KJ, Coffin L, Discepola MV, Andrews R, Woods WJ, Feaster DJ, Moskowitz JT.
    J Int AIDS Soc; 2019 Dec 01; 22(12):e25436. PubMed ID: 31860172
    [Abstract] [Full Text] [Related]

  • 4. Mobile Text Messaging to Improve Medication Adherence and Viral Load in a Vulnerable Canadian Population Living With Human Immunodeficiency Virus: A Repeated Measures Study.
    King E, Kinvig K, Steif J, Qiu AQ, Maan EJ, Albert AY, Pick N, Alimenti A, Kestler MH, Money DM, Lester RT, Murray MCM.
    J Med Internet Res; 2017 Jun 01; 19(6):e190. PubMed ID: 28572079
    [Abstract] [Full Text] [Related]

  • 5. The effect of engagement in an HIV/AIDS integrated health programme on plasma HIV-1 RNA suppression among HIV-positive people who use illicit drugs: a marginal structural modelling analysis.
    Ti L, Dong H, Kerr T, Turje RB, Parashar S, Min JE, Montaner J, Wood E, Milloy MJ.
    HIV Med; 2017 Sep 01; 18(8):580-586. PubMed ID: 28317290
    [Abstract] [Full Text] [Related]

  • 6. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.
    Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, Preston KL.
    Arch Gen Psychiatry; 1996 May 01; 53(5):409-15. PubMed ID: 8624184
    [Abstract] [Full Text] [Related]

  • 7. Pilot Randomized Controlled Trial of a Syndemics Intervention with HIV-Positive, Cocaine-Using Women.
    Jemison D, Jackson S, Oni O, Cats-Baril D, Thomas-Smith S, Batchelder A, Rodriguez A, Dilworth SE, Metsch LR, Jones D, Feaster DJ, O'Cleirigh C, Ironson G, Carrico AW.
    AIDS Behav; 2019 Sep 01; 23(9):2467-2476. PubMed ID: 31407212
    [Abstract] [Full Text] [Related]

  • 8. Group-based randomized trial of contingencies for health and abstinence in HIV patients.
    Petry NM, Weinstock J, Alessi SM, Lewis MW, Dieckhaus K.
    J Consult Clin Psychol; 2010 Feb 01; 78(1):89-97. PubMed ID: 20099954
    [Abstract] [Full Text] [Related]

  • 9. Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.
    Kennedy MC, Kerr TH, Wood E, Shoveller JA, Montaner JSG, Milloy MS.
    AIDS; 2018 May 15; 32(8):1059-1067. PubMed ID: 29424782
    [Abstract] [Full Text] [Related]

  • 10. Effect of 2 Integrated Interventions on Alcohol Abstinence and Viral Suppression Among Vietnamese Adults With Hazardous Alcohol Use and HIV: A Randomized Clinical Trial.
    Go VF, Hutton HE, Ha TV, Chander G, Latkin CA, Mai NVT, Quynh BX, Nguyen V, Sripaipan T, Lancaster KE, Blackburn N, Hershow RB, Dowdy DW, Frangakis C.
    JAMA Netw Open; 2020 Sep 01; 3(9):e2017115. PubMed ID: 32945875
    [Abstract] [Full Text] [Related]

  • 11. Longer duration of homelessness is associated with a lower likelihood of non-detectable plasma HIV-1 RNA viral load among people who use illicit drugs in a Canadian setting.
    Loh J, Kennedy MC, Wood E, Kerr T, Marshall B, Parashar S, Montaner J, Milloy MJ.
    AIDS Care; 2016 Nov 01; 28(11):1448-54. PubMed ID: 27248328
    [Abstract] [Full Text] [Related]

  • 12. Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho.
    Amstutz A, Nsakala BL, Vanobberghen F, Muhairwe J, Glass TR, Namane T, Mpholo T, Battegay M, Klimkait T, Labhardt ND.
    PLoS Med; 2020 Sep 01; 17(9):e1003325. PubMed ID: 32936795
    [Abstract] [Full Text] [Related]

  • 13. Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention.
    Coker M, Etiebet MA, Chang H, Awwal G, Jumare J, Musa BM, Babashani M, Habib AG, Dakum P, Abimiku AG, Charurat ME, Blattner WA, Eng M, Ndembi N.
    Curr HIV Res; 2015 Sep 01; 13(4):279-85. PubMed ID: 25845393
    [Abstract] [Full Text] [Related]

  • 14. Adherence intervention for HIV-infected persons who use drugs: adaptation, open trial, and pilot randomized hybrid type 1 trial protocol.
    Claborn K, Becker S, Operario D, Safren S, Rich JD, Ramsey S.
    Addict Sci Clin Pract; 2018 Apr 02; 13(1):12. PubMed ID: 29606129
    [Abstract] [Full Text] [Related]

  • 15. Impact of Abstinence and of Reducing Illicit Drug Use Without Abstinence on Human Immunodeficiency Virus Viral Load.
    Nance RM, Trejo MEP, Whitney BM, Delaney JAC, Altice FL, Beckwith CG, Chander G, Chandler R, Christopoulous K, Cunningham C, Cunningham WE, Del Rio C, Donovan D, Eron JJ, Fredericksen RJ, Kahana S, Kitahata MM, Kronmal R, Kuo I, Kurth A, Mathews WC, Mayer KH, Moore RD, Mugavero MJ, Ouellet LJ, Quan VM, Saag MS, Simoni JM, Springer S, Strand L, Taxman F, Young JD, Crane HM.
    Clin Infect Dis; 2020 Feb 14; 70(5):867-874. PubMed ID: 30994900
    [Abstract] [Full Text] [Related]

  • 16. Factors associated with 10 years of continuous viral load suppression on HAART.
    Bello KJ, Mesner O, O'Bryan TA, Won SH, Lalani T, Ganesan A, Agan BK, Okulicz JF.
    BMC Infect Dis; 2016 Jul 22; 16():351. PubMed ID: 27449671
    [Abstract] [Full Text] [Related]

  • 17. SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.
    Amstutz A, Nsakala BL, Vanobberghen F, Muhairwe J, Glass TR, Achieng B, Sepeka M, Tlali K, Sao L, Thin K, Klimkait T, Battegay M, Labhardt ND.
    BMC Infect Dis; 2018 Feb 12; 18(1):76. PubMed ID: 29433430
    [Abstract] [Full Text] [Related]

  • 18. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
    Johnson S, Rains LS, Marwaha S, Strang J, Craig T, Weaver T, McCrone P, King M, Fowler D, Pilling S, Marston L, Omar RZ, Craig M, Spencer J, Hinton M.
    Health Technol Assess; 2019 Aug 12; 23(45):1-108. PubMed ID: 31460865
    [Abstract] [Full Text] [Related]

  • 19. Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial.
    Krupitsky E, Blokhina E, Zvartau E, Verbitskaya E, Lioznov D, Yaroslavtseva T, Palatkin V, Vetrova M, Bushara N, Burakov A, Masalov D, Mamontova O, Langleben D, Poole S, Gross R, Woody G.
    Lancet HIV; 2019 Apr 12; 6(4):e221-e229. PubMed ID: 30880163
    [Abstract] [Full Text] [Related]

  • 20. Effects of incentives on viral suppression in people living with HIV who use cocaine or opiates.
    Pollock S, Toegel F, Holtyn AF, Rodewald AM, Leoutsakos JM, Fingerhood M, Silverman K.
    Drug Alcohol Depend; 2020 Jul 01; 212():108000. PubMed ID: 32362436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.